ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


Renalytix AI PLC.
45 announcements.
Time Ticker Company Announcement
07:00 RENX Renalytix AI PLC
New commercial testing facility opens in Utah
07:00 RENX Renalytix AI PLC
CMS Pricing Determination becomes effective
07:00 RENX Renalytix AI PLC
Medicare sets US national price for KidneyIntelX
07:00 RENX Renalytix AI PLC
Grant of Options
07:00 RENX Renalytix AI PLC
RenalytixAI attending City Event for Kidney Health
07:00 RENX Renalytix AI PLC
Partnership with CDPHP on KidneyIntelX
07:00 RENX Renalytix AI PLC
Board appointment
07:00 RENX Renalytix AI PLC
US CPT� reimbursement code effective
16:37 RENX Renalytix AI PLC
Result of AGM
08:00 RENX Renalytix AI PLC
Update on non-executive director appointment
07:00 RENX Renalytix AI PLC
Preliminary Medicare Pricing Determination
16:00 RENX Renalytix AI PLC
Posting of Annual Report & Accounts &Notice of AGM
07:00 RENX Renalytix AI PLC
Final Results
07:00 RENX Renalytix AI PLC
Notice of Results
07:00 RENX Renalytix AI PLC
Expansion of Chronic Kidney Disease Advisory Board
16:30 RENX Renalytix AI PLC
Total Voting Rights
07:00 RENX Renalytix AI PLC
Thomas McLain Appointed as President and CCO
07:01 RENX Renalytix AI PLC
Proposed Placing to raise £12.0m (c.US$15.0m)
07:00 RENX Renalytix AI PLC
US Exec Order on Advancing American Kidney Health
07:00 RENX Renalytix AI PLC
Positive Interim Results for Validation Study
07:00 RENX Renalytix AI PLC
FractalDx Positive Results Published in JASN
07:00 RENX Renalytix AI PLC
US CPT� Code Granted for KidneyIntelX(TM)
07:00 RENX Renalytix AI PLC
Positive results from FractalDx study published
07:00 RENX Renalytix AI PLC
KidneyIntelX commercial scale production milestone
07:00 RENX Renalytix AI PLC
CLIA Certificate Number issued for Renalytix Lab
07:00 RENX Renalytix AI PLC
Expansion of FractalDx core investigator group
07:00 RENX Renalytix AI PLC
University Medical Center Groningen collaboration
14:05 RENX Renalytix AI PLC
Second Price Monitoring Extn
14:00 RENX Renalytix AI PLC
Price Monitoring Extension
07:00 RENX Renalytix AI PLC
FDA grants Breakthrough Device designation
12:55 RENX Renalytix AI PLC
Holding(s) in Company
07:00 RENX Renalytix AI PLC
Publication of confirmation study results
07:00 RENX Renalytix AI PLC
Half-year Report
07:00 RENX Renalytix AI PLC
RenalytixAI Forms Core Investigator Group
07:00 RENX Renalytix AI PLC
Investor briefing
07:00 RENX Renalytix AI PLC
Appointment of Nomad and Joint Broker
07:00 RENX Renalytix AI PLC
Joint venture partnership agreement with AKESOgen
07:00 RENX Renalytix AI PLC
RenalytixAI Expands Leadership Team
07:00 RENX Renalytix AI PLC
Initiates Clinical Validation Study
07:00 RENX Renalytix AI PLC
Clarification re. lock-up restrictions
07:00 RENX Renalytix AI PLC
Exercise of Option for Exclusive License
10:30 RENX Renalytix AI PLC
Holding(s) in Company
16:50 RENX Renalytix AI PLC
Holding(s) in Company
07:00 RENX Renalytix AI PLC
Director/PDMR Shareholding
07:00 RENX Renalytix AI PLC
RENX Admission to AIM and First Day of Dealings